Clinical trials

  • DURVALUMAB for Non-small cell lung cancer
  • SABIRNETUG for Alzheimer's disease | Mild cognitive impairment due to Alzheimer's disease
  • VHB937 for Amyotrophic lateral sclerosis
  • Gemcitabine for Recurrent glioblastoma | Glioblastoma multiforme
  • ZELENECTIDE PEVEDOTIN for Nectin-4 expressing advanced malignancies
  • Pamidronate disodium for Sternocostoclavicular hyperostosis | Chronic nonbacterial osteitis | Inflammation of sternal region
  • VEDOLIZUMAB for Ulcerative colitis
  • RAG1-LV-CD34+ CELLS for Severe combined immunodeficiency (RAG1 deficiency)
  • Tetanus toxoid; Neisseria meningitidis Group C (strain C11) polysaccharide (de-O-acetylated) conjugated to tetanus toxoid; Neisseria meningitidis Group A polysaccharide conjugated to tetanus toxoid carrier protein; Neisseria meningitidis Group W-135 polysaccharide conjugated to tetanus toxoid carrier protein; Neisseria meningitidis Group Y polysaccharide conjugated to tetanus toxoid carrier protein for Meningococcal infection
  • Triamcinolone Hexacetonide for Carpal tunnel syndrome
  • STX-241 for Non-small cell lung cancer (NSCLC) — locally advanced or metastatic, resistant to EGFR tyrosine kinase inhibitors (TKIs)
  • KYV-101 for Generalized myasthenia gravis